Gait Dysfunction in Motoric Cognitive Risk Syndrome

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established. Objective: To systematically assess clinical gait abnormalities in older adults with MCR. Methods: Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n=41), slow swing time (MCRsw, n=21), high stride length variability (MCRslv, n=24), and high swing time variability (MCRswv, n=25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n=81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases. Results: Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value=0.033) but not decline on cognitive scores (p-value=0.056). Conclusion: Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.

Original languageEnglish (US)
Pages (from-to)S95-S103
JournalJournal of Alzheimer's Disease
Volume71
Issue numbers1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Gait
Independent Living
Dementia
Phenotype

Keywords

  • Cognition
  • gait
  • motoric cognitive risk syndrome

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Gait Dysfunction in Motoric Cognitive Risk Syndrome. / Ayers, Emmeline; Verghese, Joe.

In: Journal of Alzheimer's Disease, Vol. 71, No. s1, 01.01.2019, p. S95-S103.

Research output: Contribution to journalArticle

@article{9518c76b105d4b12b28f5a476bae671c,
title = "Gait Dysfunction in Motoric Cognitive Risk Syndrome",
abstract = "Background: Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established. Objective: To systematically assess clinical gait abnormalities in older adults with MCR. Methods: Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47{\%} women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n=41), slow swing time (MCRsw, n=21), high stride length variability (MCRslv, n=24), and high swing time variability (MCRswv, n=25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n=81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases. Results: Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61{\%}). Neurological (range 24 to 46{\%}) and non-neurological gait abnormalities (33 to 61{\%}) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46{\%}) and non-neurological gaits in MCRv (61{\%}). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value=0.033) but not decline on cognitive scores (p-value=0.056). Conclusion: Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.",
keywords = "Cognition, gait, motoric cognitive risk syndrome",
author = "Emmeline Ayers and Joe Verghese",
year = "2019",
month = "1",
day = "1",
doi = "10.3233/JAD-181227",
language = "English (US)",
volume = "71",
pages = "S95--S103",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "s1",

}

TY - JOUR

T1 - Gait Dysfunction in Motoric Cognitive Risk Syndrome

AU - Ayers, Emmeline

AU - Verghese, Joe

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established. Objective: To systematically assess clinical gait abnormalities in older adults with MCR. Methods: Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n=41), slow swing time (MCRsw, n=21), high stride length variability (MCRslv, n=24), and high swing time variability (MCRswv, n=25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n=81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases. Results: Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value=0.033) but not decline on cognitive scores (p-value=0.056). Conclusion: Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.

AB - Background: Motoric cognitive risk (MCR) syndrome is a cognitive-motor syndrome associated with increased risk of transition to dementia. The clinical phenotype of MCR is not yet established. Objective: To systematically assess clinical gait abnormalities in older adults with MCR. Methods: Of the 522 community-dwelling non-demented adults aged 65 and older enrolled in the Central Control of Mobility in Aging study, 43 were diagnosed with MCR (47% women) based on presence of cognitive complaints and slow gait velocity (MCRv). Four additional subtypes of MCR were defined by substituting slow gait with short stride length (MCRsl, n=41), slow swing time (MCRsw, n=21), high stride length variability (MCRslv, n=24), and high swing time variability (MCRswv, n=25). The prevalence of clinical gait abnormalities (neurological or non-neurological) in MCR overall (n=81) and subtypes was studied. We also examined if gait abnormalities predicted further cognitive and functional decline in MCR cases. Results: Most clinical gait abnormalities were mild (walked without assistance) in the five MCR subtypes (44 to 61%). Neurological (range 24 to 46%) and non-neurological gait abnormalities (33 to 61%) were common in all MCR subtypes. Neurological gaits were most frequent in MCRsl (46%) and non-neurological gaits in MCRv (61%). Over a median 3.02 years of follow-up, presence of gait abnormality in MCR cases at baseline predicted worsening disability scores (estimate 0.17, p-value=0.033) but not decline on cognitive scores (p-value=0.056). Conclusion: Clinical gait abnormalities are common in MCR syndrome and its subtypes, and are associated with accelerated functional decline.

KW - Cognition

KW - gait

KW - motoric cognitive risk syndrome

UR - http://www.scopus.com/inward/record.url?scp=85072586847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072586847&partnerID=8YFLogxK

U2 - 10.3233/JAD-181227

DO - 10.3233/JAD-181227

M3 - Article

C2 - 30909242

AN - SCOPUS:85072586847

VL - 71

SP - S95-S103

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - s1

ER -